# A pilot study of multimodal MRI for the preoperative assessment of triple-negative breast cancer

**Authors:** Shan Luo, Rong Lin, Hui Lin, Zejuan Zhan, Xiaomin Wu, Langlang Tang, Xionghua Huang, Yuanying Liu, Pengfei Li, Junye Yao, Peng Wu, Xueyan Liao

PMC · DOI: 10.3389/fonc.2026.1714620 · Frontiers in Oncology · 2026-02-04

## TL;DR

This study shows that combining different MRI techniques can accurately identify triple-negative breast cancer before surgery.

## Contribution

The study introduces a combined MRI model that improves diagnostic accuracy for triple-negative breast cancer compared to individual methods.

## Key findings

- TNBC lesions showed significantly different MRI parameters compared to non-TNBC lesions.
- A combined MRI model achieved 97.7% diagnostic accuracy for identifying TNBC.
- Enhanced T1 and T2 values correlated weakly with the Ki-67 proliferation index in TNBC.

## Abstract

To evaluate the diagnostic value of multimodal MRI by comprising quantitative mapping, diffusion-weighted imaging (DWI), and dynamic contrast-enhanced MRI (DCE-MRI) in differentiating triple-negative breast cancer (TNBC) from non-TNBC, and to investigate the correlation between significant quantitative mapping parameters and the Ki-67 proliferation index.

This prospective study enrolled 120 patients with invasive breast cancer (30 TNBC and 90 non-TNBC) who underwent preoperative quantitative mapping, DWI, and DCE-MRI. DCE-MRI parameters (RE, ME, MRE, T0, TTP, WI, WO, BOE), DWI metrics (ADCmin, ADCmean, rADCmin, rADCmean), and quantitative mapping parameters (Native T1, Enhanced T1, ΔT1, ΔT1%, T2) were compared between groups. Diagnostic performance was evaluated using receiver operating characteristic (ROC) analysis and area under the curve (AUC) for both individual significant parameters and a combined predictive model. Pearson’ s correlation coefficient was used to analyze the relationship between quantitative mapping parameters and the Ki-67 index.

Compared to the non-TNBC group, TNBC lesions exhibited significantly lower RE, ME, WI, WO, and ΔT1% (p < 0.05), but higher Enhanced T1 and T2 values (p < 0.05). The combined model integrating DCE-MRI and quantitative mapping achieved the highest diagnostic accuracy (AUC = 0.977), outperforming DCE-MRI alone (AUC = 0.951) and quantitative mapping alone (AUC = 0.864), with sensitivity and specificity of 93.3% and 92.2%, respectively. In TNBC, the Ki-67 index showed a weak positive correlation with Enhanced T1 (r = 0.387, p < 0.05) and T2 (r = 0.381, p < 0.05).

Parameters including RE, ME, WI, WO, Enhanced T1, ΔT1%, and T2 serve as valuable imaging biomarkers for the preoperative identification of TNBC. Integrating quantitative mapping with DCE-MRI significantly enhances diagnostic performance, offering a robust approach for differentiating TNBC from non-TNBC subtypes.

## Linked entities

- **Diseases:** triple-negative breast cancer (MONDO:0005494), breast cancer (MONDO:0004989)

## Full-text entities

- **Genes:** ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, NR4A1 (nuclear receptor subfamily 4 group A member 1) [NCBI Gene 3164] {aka GFRP1, HMR, N10, NAK-1, NGFIB, NP10}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}
- **Diseases:** Ductal Carcinoma (MESH:D044584), Breast cancer (MESH:D001943), TNBC (MESH:D064726), hepatocellular carcinoma (MESH:D006528), necrosis (MESH:D009336), colon cancer (MESH:D015179), invasive lobular carcinomas (MESH:D018275), XL (MESH:D000080345), hemorrhage (MESH:D006470), hypoxic (MESH:D002534), HL (MESH:C538324), SL (MESH:C564794), fibrosis (MESH:D005355), edema (MESH:D004487), Tumor (MESH:D009369)
- **Chemicals:** lipid (MESH:D008055), gadolinium (MESH:D005682), DCE (-), water (MESH:D014867), hyaluronic acid (MESH:D006820), gold (MESH:D006046), Gadobenate dimeglumine (MESH:C064572), cabazitaxel (MESH:C552428)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12913062/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12913062/full.md

## References

54 references — full list in the complete paper: https://tomesphere.com/paper/PMC12913062/full.md

---
Source: https://tomesphere.com/paper/PMC12913062